← Back to Analyst Consensus 
GDRX Hold
GoodRx Holdings, Inc.
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 21, 2026 | Barclays | maintain | Underweight → Underweight | — | 53% |
| Aug 13, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 11, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 14, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 11, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Mar 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 3, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 2, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Feb 27, 2026 | Mizuho | maintain | Neutral → Neutral | $3 | 52% |
| Feb 27, 2026 | JP Morgan | downgrade | Overweight → Neutral | $0 | 54% |
| Jan 22, 2026 | Jefferies | downgrade | Buy → Hold | $2.75 | 52% |
| Jan 9, 2026 | Citigroup | maintain | Buy → Buy | $4.5 | 54% |
| Dec 18, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| Dec 9, 2025 | Barclays | initiate | — → Underweight | $3 | 53% |
| Nov 11, 2025 | JP Morgan | maintain | Overweight → Overweight | $5 | 54% |
| Nov 10, 2025 | TD Cowen | maintain | Buy → Buy | $6 | 54% |
| Nov 6, 2025 | UBS | maintain | Neutral → Neutral | $4 | 54% |
| Nov 6, 2025 | Mizuho | maintain | Neutral → Neutral | $4 | 52% |
| Aug 11, 2025 | UBS | maintain | Neutral → Neutral | $4.25 | 54% |
| May 13, 2025 | UBS | maintain | Neutral → Neutral | $5.25 | 54% |
| May 9, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $5 | 54% |
| Apr 29, 2025 | Wells Fargo | maintain | Overweight → Overweight | $7 | 54% |
| Apr 10, 2025 | Truist Securities | maintain | Hold → Hold | $5.5 | 55% |
| Feb 28, 2025 | Wells Fargo | maintain | Overweight → Overweight | $8 | 54% |
| Jan 10, 2025 | Citigroup | maintain | Buy → Buy | $6.25 | 54% |
| Jan 8, 2025 | Keybanc | maintain | Overweight → Overweight | $6 | 53% |
| Dec 17, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $6 | 54% |
| Nov 13, 2024 | Citigroup | maintain | Buy → Buy | $7 | 54% |
| Nov 11, 2024 | Barclays | maintain | Overweight → Overweight | $6 | 53% |
| Aug 16, 2024 | RBC Capital | reiterate | Outperform → Outperform | $10 | 55% |
| Aug 9, 2024 | Citigroup | maintain | Buy → Buy | $10 | 54% |
| Aug 9, 2024 | UBS | maintain | Neutral → Neutral | $8.5 | 54% |
| Jun 10, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $9.5 | 54% |
| May 23, 2024 | RBC Capital | upgrade | Sector Perform → Outperform | $10 | 55% |
| May 20, 2024 | Barclays | maintain | Overweight → Overweight | $10 | 53% |
| May 16, 2024 | Raymond James | upgrade | Market Perform → Outperform | $10 | 54% |
| May 16, 2024 | TD Cowen | maintain | Buy → Buy | $16 | 54% |
| Apr 10, 2024 | Keybanc | upgrade | Sector Weight → Overweight | $9 | 53% |
| Mar 25, 2024 | Wells Fargo | upgrade | Equal-Weight → Overweight | $10 | 54% |
| Mar 8, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $8 | 55% |
| Mar 1, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $7.5 | 54% |
| Mar 1, 2024 | UBS | maintain | Neutral → Neutral | $8 | 54% |
| Mar 1, 2024 | RBC Capital | maintain | Sector Perform → Sector Perform | $8 | 55% |
| Mar 1, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $7.5 | 54% |
| Mar 1, 2024 | Truist Securities | maintain | Hold → Hold | $8 | 55% |
| Mar 1, 2024 | TD Cowen | maintain | Outperform → Outperform | $14 | 54% |
| Mar 1, 2024 | JP Morgan | upgrade | Neutral → Overweight | $10 | 54% |
| Mar 1, 2024 | Barclays | maintain | Overweight → Overweight | $9 | 53% |
Price Target Trend
Apr 3, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days